top of page
Screenshot[1]-01.png

Benzodiazepines Research

Benzodiazepine Prescribing & Tapering

TSRG has compiled an array of resources to bring increased visibility to the risks of prolonged use and potential injuries such as benzodiazepine induced neurological dysfunction (BIND).

Peer Recovery Training

Benzodiazepine Peer Recovery Support Specialist Training Course

Action Work Group

Benzodiazepine Action Work Group (BAWG) Resources

Community Partners

Featured Media & Podcasts

Medicating Normal Screening

The Benzodiazepine Action Work Group of the Colorado Consortium for Prescription Drug Abuse Prevention hosted a screening followed by a panel discussion and Q&A on April 10, 2021.

Panel Discussion

Benzodiazepine Prescribing and Tapering

Recommended Benzodiazepines Articles

Survey
Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey

Ritvo AD, Foster DE, Huff C, Finlayson AJR, Silvernail B, Martin P

2023

Internet Survey
Enduring neurological sequelae of benzodiazepine use: an Internet survey

Huff C, Finlayson AR, Foster DE, Martin PR.

2023

Patient Survey
Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey

Reid Finlayson AJ, Macoubrie J, Huff C, Foster DE, Martin PR.

2022

Perspective
Surviving Benzodiazepines: A Patient's and Clinician's Perspectives

Silvernail CM, Wright SL.

2022

Article
Benzodiazepine Withdrawal Tied to Serious Long-Term Harms

Lane C.
The findings of a large survey support the FDA’s “boxed warning” from 2020.

2022

Toolkit Development
Supporting safe and gradual reduction of long-term benzodiazepine receptor agonist use: development of the SAFEGUARDING-BZRAs toolkit using a codesign approach

Lynch T, Ryan C, Bradley C, Foster D, Huff C, Hutchinson S, et al.

2022

Narrative Review
Limited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review

Wright SL.

2020

TSRG Logo White.png

Working collaboratively with communities, researchers, and policymakers to create lasting public health impact.

  • Facebook
  • Instagram
  • LinkedIn
  • X
  • Youtube
Candid seal 2026.png
​info@tsrg.org
+1 720-234-8191
P.O. Box 371342,
Denver, CO 80237
83-2233301

Disclaimer (Last updated: May 22, 2026) The information provided by The Schreiber Research Group is for educational purposes only and may evolve as new research emerges. It is not a substitute for professional medical advice.

​

Images used under license from Shutterstock.com (Homepage, Blog, Contact Us, Donate, Our Team and Research). Artwork on the Benzodiazepine webpage was created by Akhtar Badshah (Kirkland, WA). The Path Forward logo was designed by Salem Hansen (Aurora, CO, Los Angeles, CA). 

bottom of page